Development and validation of CT-based radiomics signature for overall survival prediction in multi-organ cancer
The malignant tumors in nature share some common morphological characteristics.
Radiomics is not only images but also data; we think that a probability exists in a set of …
Radiomics is not only images but also data; we think that a probability exists in a set of …
Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a …
Objectives To develop and validate a preoperative CT-based nomogram combined with
radiomic and clinical–radiological signatures to distinguish preinvasive lesions from …
radiomic and clinical–radiological signatures to distinguish preinvasive lesions from …
Multicenter evaluation of MRI‐based radiomic features: A phantom study
Introduction This work describes the development of a novel radiomics phantom designed
for magnetic resonance imaging (MRI) that can be used in a multicenter setting. The …
for magnetic resonance imaging (MRI) that can be used in a multicenter setting. The …
Radiomics-based deep learning prediction of overall survival in non-small-cell lung cancer using contrast-enhanced computed tomography
Simple Summary The five-year survival rate of non-small-cell lung cancer (NSCLC), which
accounts for 85% of all lung cancer cases, is only 10–20%. A reliable prediction model of …
accounts for 85% of all lung cancer cases, is only 10–20%. A reliable prediction model of …
Precision digital oncology: emerging role of radiomics-based biomarkers and artificial intelligence for advanced imaging and characterization of brain tumors
R Forghani - Radiology: Imaging Cancer, 2020 - pubs.rsna.org
Advances in computerized image analysis and the use of artificial intelligence–based
approaches for image-based analysis and construction of prediction algorithms represent a …
approaches for image-based analysis and construction of prediction algorithms represent a …
Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy
D Xie, F Xu, W Zhu, C Pu, S Huang, K Lou, Y Wu… - Frontiers in …, 2022 - frontiersin.org
Objective To assess the validity of pre-and posttreatment computed tomography (CT)-based
radiomics signatures and delta radiomics signatures for predicting progression-free survival …
radiomics signatures and delta radiomics signatures for predicting progression-free survival …
Predicting PD-L1 expression status in patients with non-small cell lung cancer using [18F]FDG PET/CT radiomics
X Zhao, Y Zhao, J Zhang, Z Zhang, L Liu, X Zhao - EJNMMI research, 2023 - Springer
Background In recent years, immune checkpoint inhibitor (ICI) therapy has greatly changed
the treatment prospects of patients with non-small cell lung cancer (NSCLC). Among the …
the treatment prospects of patients with non-small cell lung cancer (NSCLC). Among the …
A CT-based radiomics approach to predict nivolumab response in advanced non-small-cell lung cancer
C Liu, J Gong, H Yu, Q Liu, S Wang, J Wang - Frontiers in Oncology, 2021 - frontiersin.org
Purpose This study aims to develop a CT-based radiomics model to predict clinical
outcomes of advanced non-small-cell lung cancer (NSCLC) patients treated with nivolumab …
outcomes of advanced non-small-cell lung cancer (NSCLC) patients treated with nivolumab …
Risk score generated from CT-based radiomics signatures for overall survival prediction in non-small cell lung cancer
Simple Summary Despite recent advancements in lung cancer treatment, individuals with
lung cancer have a dismal 5-year survival rate of only 15%. In patients with non-small cell …
lung cancer have a dismal 5-year survival rate of only 15%. In patients with non-small cell …
Computed tomography–based radiomics machine learning classifiers to differentiate type I and type II epithelial ovarian cancers
J Li, X Li, J Ma, F Wang, S Cui, Z Ye - European radiology, 2023 - Springer
Objectives To compare computed tomography (CT)–based radiomics for preoperatively
differentiating type I and II epithelial ovarian cancers (EOCs) using different machine …
differentiating type I and II epithelial ovarian cancers (EOCs) using different machine …